| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10038413 | HBV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
| TVIS30074496 | HIV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
| TVIS30074497 | HIV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
| TVIS30079787 | HIV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
| TVIS30022806 | HIV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
| TVIS30022807 | HIV | ENSG00000000938.13 | protein_coding | FGR | No | No | 2268 | P09769 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FGR |
|---|---|
| DrugBank ID | DB06616 |
| Drug Name | Bosutinib |
| Target ID | BE0005539 |
| UniProt ID | P09769 |
| Regulation Type | inhibitor |
| PubMed IDs | 23493838 |
| Citations | Amsberg GK, Koschmieder S: Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia. Onco Targets Ther. 2013;6:99-106. doi: 10.2147/OTT.S19901. Epub 2013 Mar 4. |
| Groups | Approved |
| Direct Classification | 4-aminoquinolines |
| SMILES | COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl |
| Pathways | Bosutinib Inhibition of BCR-ABL |
| PharmGKB | |
| ChEMBL | CHEMBL288441 |
